Sirona Biochem Corp.  

(Public, CVE:SBM)   Watch this stock  
Find more results for cve:sbm
0.110
-0.005 (-4.35%)
Apr 24 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.10 - 0.11
52 week 0.08 - 0.20
Open 0.11
Vol / Avg. 267,300.00/152,206.00
Mkt cap 13.15M
P/E     -
Div/yield     -
EPS -0.04
Shares 119.59M
Beta -0.53
Inst. own     -

Key stats and ratios

Q3 (Jul '13) 2012
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -81.33% -97.67%
Return on average equity -141.04% -135.45%
CDP Score - -

Address

605-889 West Pender St.
VANCOUVER, BC V6C 3B2
Canada
+1-604-6414466 (Phone)
+1-604-6085471 (Fax)

Website links

Description

Sirona Biochem Corp. is a Canada-based, development-stage company. Sirona is a product-pipeline company with a proprietary technology platform developed at its laboratory facility in France. The Company specializes in the stabilization of carbohydrate molecules. The Company´┐Żs compounds are being developed for both pharmaceutical and cosmetic marketplaces. It is also focused on advancing three programs: therapeutics, which includes sodium glucose co-transporter (SGLT) and cancer antigen; cosmetic agents, which includes skin lightener and anti-aging and biological ingredients, which includes inducers and adjuvants. Its two most advanced programs include a diabetes treatment and a cosmetic skin lightening agent.

Officers and directors

Howard Verrico M.D., Chairman of the Board, Founder, Secretary
Neil Belenkie Chief Executive Officer
Christopher D. Hopton Chief Financial Officer, Director
Geraldine Deliencourt-Godefroy Chief Scientific Officer, Director
David S. Moore Director
Michael Rogers Director
Nigel Terrett Director
Alex Marazzi Independent Director